Literature DB >> 6411235

Precipitation of hepatic encephalopathy by propranolol in cirrhosis.

D Tarver, R P Walt, A A Dunk, W J Jenkins, S Sherlock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6411235      PMCID： PMC1548970          DOI： 10.1136/bmj.287.6392.585

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  2 in total

1.  Propranolol--a medical treatment for portal hypertension?

Authors:  D Lebrec; O Nouel; M Corbic; J P Benhamou
Journal:  Lancet       Date:  1980-07-26       Impact factor: 79.321

2.  Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study.

Authors:  D Lebrec; T Poynard; P Hillon; J P Benhamou
Journal:  N Engl J Med       Date:  1981-12-03       Impact factor: 91.245
  2 in total
  8 in total

1.  Pharmacology of propranolol in patients with cirrhosis and portal hypertension.

Authors:  M J Arthur; A R Tanner; C Patel; R Wright; A G Renwick; C F George
Journal:  Gut       Date:  1985-01       Impact factor: 23.059

2.  Sclerotherapy versus sclerotherapy and propranolol in the prevention of rebleeding from oesophageal varices: a randomised study.

Authors:  S S Elsayed; G Shiha; M Hamid; F M Farag; F Azzam; M Awad
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

3.  Endoscopic variceal pressure measurements: response to isosorbide dinitrate.

Authors:  J Dawson; P Gertsch; F Mosimann; R West; E Elias
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

4.  Effect of nadolol on liver haemodynamics and function in patients with cirrhosis.

Authors:  C Merkel; D Sacerdoti; G F Finucci; R Zuin; G Bazzerla; M Bolognesi; A Gatta
Journal:  Br J Clin Pharmacol       Date:  1986-06       Impact factor: 4.335

5.  Prophylaxis of first variceal hemorrhage in patients with liver cirrhosis.

Authors:  T Sauerbruch; G Kleber; A Gerbes; G Paumgartner
Journal:  Klin Wochenschr       Date:  1986-12-15

6.  Long-term effect of nadolol on quantitative liver function tests in patients with cirrhosis.

Authors:  C Merkel; A Gatta; D Sacerdoti; M Bolognesi; M Rondana; L Caregaro; G F Finucci; A Ruol
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 7.  Safety of propranolol in portal hypertension. Conventional and long acting formulations.

Authors:  P C Hayes
Journal:  Drugs       Date:  1989       Impact factor: 9.546

Review 8.  Drug administration in chronic liver disease.

Authors:  J F Westphal; J M Brogard
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.228
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.